About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingPhase 4NCT07073053

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

The investigators plan to enroll 60 patients from the outpatient clinics or inpatient wards of the Metabolism and Cardiology departments who, within the past three months, have undergone coronary angi...

Lead sponsor: Taipei Veterans General Hospital, Taiwan•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Chin-Sung Kuo, M.D., Ph.D.

CONTACT

+886-2-28757513 [email protected]

Sponsors

Lead Sponsor

Taipei Veterans General Hospital, Taiwan

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. adults (\>=20 years old),
•2. Type 2 Diabetes with coronary arterial disease underwent angioplasty within 3 months with SGLT2 inhibitors -

Exclusion Criteria

•1. age\<20 years old,
•2. pregnant women,
•3. eGFR\<30 ml/min/1.73m2,
•4. received GLP-1 agonist in the recent 3 months -

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease

NCT07510438 · Coronary Arterial Disease (CAD)

RECRUITINGPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 18, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhasePHASE4

Enrollment60

Start dateOct 2025

Last updatedJul 18, 2025

Condition

Glucagon-Like Peptide-1 Receptor Agonists Type 2 Diabetes Coronary Arterial Disease (CAD)

Locations shown

Taipei Veterans General Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 18, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions